Summary
Guardant Health, Inc. filed an 8-K on May 7, 2020, primarily to announce its financial results for the fiscal quarter ended March 31, 2020, through an accompanying press release (Exhibit 99.1). This filing serves as notification to investors of the company's performance during the first quarter of 2020. Investors should refer to the furnished press release for the specific financial details and operational highlights.
Key Highlights
- 1Guardant Health announced its financial results for the fiscal quarter ended March 31, 2020.
- 2The company's Q1 2020 results were disclosed via a press release furnished as Exhibit 99.1 to the 8-K.
- 3This filing primarily serves as a method to disseminate financial performance information.
- 4The information provided is furnished and not deemed 'filed' for purposes of Section 18 of the Exchange Act.
- 5Investors are directed to Exhibit 99.1 for the detailed financial outcomes and operational updates for the quarter.
Frequently Asked Questions
The main purpose of this 8-K filing is to publicly announce and provide investors with Guardant Health's financial results for the fiscal quarter ended March 31, 2020. The detailed results are contained within an attached press release.
The specific financial results for the fiscal quarter ended March 31, 2020, are located in the press release furnished as Exhibit 99.1 to this 8-K filing.
No, the information furnished in this 8-K filing, including the press release, is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934. This means it does not carry the same legal liabilities as formally filed documents under that specific section.